Cargando…
Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice
BACKGROUND: SARS-CoV-2 Omicron variants are highly resistant to vaccine-induced immunity and human monoclonal antibodies. METHODS: We previously reported that two nanobodies, P17 and P86, potently neutralize SARS-CoV-2 VOCs. In this study, we modified these nanobodies into trimers, called TP17 and T...
Autores principales: | Nagata, Kayoko, Utsumi, Daichi, Asaka, Masamitsu N., Maeda, Ryota, Shirakawa, Kotaro, Kazuma, Yasuhiro, Nomura, Ryosuke, Horisawa, Yoshihito, Yanagida, Yohei, Kawai, Yugo, Sato, Kei, Yamaoka, Yutaro, Miyakawa, Kei, Ryo, Akihide, Yasutomi, Yasuhiro, Imura, Akihiro, Takaori-Kondo, Akifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701191/ https://www.ncbi.nlm.nih.gov/pubmed/36435945 http://dx.doi.org/10.1038/s43856-022-00213-5 |
Ejemplares similares
-
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron
por: Maeda, Ryota, et al.
Publicado: (2022) -
APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression
por: Yamazaki, Hiroyuki, et al.
Publicado: (2020) -
d-Alanine as a biomarker and a therapeutic option for severe influenza virus infection and COVID-19
por: Kimura-Ohba, Shihoko, et al.
Publicado: (2023) -
Highly susceptible SARS-CoV-2 model in CAG promoter–driven hACE2-transgenic mice
por: Asaka, Masamitsu N., et al.
Publicado: (2021) -
ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells
por: Kazuma, Yasuhiro, et al.
Publicado: (2022)